LEADER 02281nam  2200493   450 
001 9910346732703321
005 20231027212101.0
010   $a1-83962-200-8
010   $a1-83962-199-0
035   $a(CKB)4920000000094383
035   $a(NjHacI)994920000000094383
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/40610
035   $a(MiAaPQ)EBC30390279
035   $a(Au-PeEL)EBL30390279
035   $a(EXLCZ)994920000000094383
100   $a20221017d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAldosterone-Mineralocorticoid Receptor $eCell Biology to Translational Medicine /$fBrian Harvey, Frederic Jaisser, editors
205   $a1st ed.
210   $cIntechOpen$d2019
210  1$aLondon :$cIntechOpen,$d[2019]
210  4$dİ2019
215   $a1 online resource (300 pages) $cillustrations
311   $a1-83962-198-2 
320   $aIncludes bibliographical references and index.
330   $aThis book is an open access dissemination of the EU COST Action ADMIRE in Aldosterone/Mineralocorticoid Receptor (MR) physiology and pathophysiology. Aldosterone is the major hormone regulating blood pressure. Alterations in blood levels of aldosterone and genetic mutations in the MR receptor are major causes of hypertension and comorbidities. Many of the drugs in clinical use, and in development for treating hypertension, target aldosterone and MR actions in the kidney and cardiovascular system. The ADMIRE book assembles review chapters from 16 European ADMIRE laboratories providing the latest insights into mechanisms of aldosterone synthesis/secretion, aldosterone/MR physiology and signaling, and the pathophysiological roles of aldosterone/MR activation.
606   $aAldosterone$xPhysiological effect
610   $aMedicine
610   $aEndocrinology
610   $aHealth Sciences
615  0$aAldosterone$xPhysiological effect.
676   $a615.364
702   $aHarvey$b Brian
702   $aJaisser$b Frederic
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910346732703321
996   $aAldosterone-Mineralocorticoid Receptor$93386093
997   $aUNINA